Today’s article skips the abstract theory and focuses on the porcine coronavirus problems that cause the most headaches in everyday practice, with a practical review. The aim is to help break the habitual misconception that “diarrhea means treating it as PED,” clarify the differences among six types of porcine coronaviruses, highlight secretory IgA in sow milk as a core protective factor, and explain why mucosal immunity is the key line of defense against viral transmission.
Below, I’ll outline a practical approach to prevention and control, covering pathogen identification, clinical classification, immune mechanisms, and practical precautions, to help you avoid detours and reduce piglet losses.
Traditional pig farming has long been affected by entrenched misconceptions about coronaviruses. Many farmers equate all cases of diarrhea in pigs with porcine epidemic diarrhea virus and apply a single diagnostic and treatment plan, overlooking key differences such as age and neurological signs. Even inactivated vaccines have failed to provide the expected protection. Some have even indiscriminately used material from dead pigs for feedback, ultimately blaming vaccine quality or failure for unsuccessful prevention and control, while completely missing the core principles of viral protection.
From the perspective of their essential viral properties, porcine coronaviruses comprise 6 subtypes, which can be classified into three types: enteric, respiratory, and neurological. Different strains invade different target organs, so the corresponding prevention and control approaches differ fundamentally.
The core of piglet protection relies on secretory IgA antibodies in sow’s milk, not conventional serum IgG antibodies. Large amounts of secretory IgA can only be generated by stimulating the intestinal mucosa with live virus. This means that the core line of defense against coronavirus is rooted in the intestinal mucosa, rather than relying solely on the systemic immune barrier built by injectable vaccines.
Differences in the pathogens of the six porcine coronaviruses form the underlying logic for prevention and control: PEDV and TGEV target the intestinal mucosa and are the main causes of diarrheal diseases; PRCV is a respiratory pathogen that often worsens disease through coinfection with PRRSV; PHEV is the only coronavirus that causes neurological symptoms and is often associated with the large-scale introduction of replacement pigs. Differences in tissue tropism determine that prevention and control cannot follow a one-size-fits-all approach; the infection target must first be identified before a corresponding strategy is developed.
Maternal IgA is the core line of defense for piglet intestinal immunity. After live virus stimulates the digestive tract through feedback feeding or natural infection, IgA-secreting cells in the intestinal mucosa migrate to the mammary gland, providing piglets with local passive immunity through regular milk. Intramuscular injection of inactivated vaccines only increases serum IgG and contributes very little to sIgA in regular milk. This also explains why relying solely on vaccines provides insufficient protection.
Cognitive biases are common in clinical practice: attributing all diarrhea to PEDV, mistakenly believing that inactivated vaccines can replace mucosal immunity, and blindly using feedback to spread wild-type pathogens. These misjudgments all stem from failing to distinguish pathogen types and to focus on the central role of IgA immunity. Future prevention and control should center on mucosal immunity and adopt targeted measures based on pathogen classification to avoid wasting immune resources.
The porcine coronavirus family includes six types of pathogens. PRCV and TGEV are especially easy to confuse. PRCV is a variant of TGEV with a deletion in the S gene. The two viruses differ significantly in their target organs, and their corresponding prevention and control strategies are completely different.
Precisely distinguishing between the two viruses has significant clinical value. PRCV infection can induce the body to produce neutralizing antibodies against TGEV, enabling colostral protection rates in newborn piglets to reach 87.5%~100%. This characteristic can be directly applied in production immunization design.
The six types of porcine coronaviruses fall into three major invasion pathways: intestinal, respiratory, and neurological. Although they belong to the same coronavirus family, they target different organs, so their prevention and control approaches differ fundamentally. Blindly applying a single prevention and control plan will greatly reduce protective effectiveness; accurate identification is a core prerequisite for scientifically sound prevention and control.
The three core symptoms—diarrhea, labored breathing, and tremors—correspond to three different clinical types of porcine coronavirus. Accurately identifying the symptom type is a core prerequisite for developing a prevention and control strategy; misdiagnosis and indiscriminate treatment in clinical practice can directly lead to prevention and control failure.
The diarrheal type is the most common type on pig farms and is caused jointly by three coronaviruses: PEDV, TGEV, and PDCoV. Typical signs include watery diarrhea, vomiting, and dehydration. The younger the piglets, the faster the disease progresses and the higher the mortality rate. The respiratory type is primarily caused by PRCV and is concentrated in growing pigs aged 10 to 15 weeks. It is often coinfected with PRRSV, which can greatly aggravate respiratory symptoms and make prevention and control more difficult.
The neurological type is the one most easily missed in diagnosis. PHEV is the only porcine coronavirus that causes neurological symptoms. Piglets younger than 4 weeks show typical signs of vomiting and weight loss. Cases are often associated with the batch introduction of replacement pigs. When diarrhea cases accompanied by neurological symptoms are seen clinically, PHEV must be included in the differential diagnosis to avoid misdiagnosis or missed diagnosis.
We break down the complete transmission chain of maternal immunity to help everyone put the protection process into practice at every step. Piglets have no maternal immunoglobulins of their own at birth and rely entirely on colostrum and milk for immune protection. This protection pathway consists of five steps:
Step one: Introduce live virus into the digestive tract through feedback feeding or natural infection to stimulate an immune response in the intestinal mucosa;
Step two: About eight tenths of IgA-secreting cells colonize the intestinal mucosal region, initiating a local immune response;
Step three: immune cells differentiate into plasmablasts, migrate into mammary tissue, and begin synthesizing and secreting IgA;
Step four: The composition of breast milk changes. Colostrum is dominated by IgG, while mature milk gradually shifts to being dominated by IgA;
Step five: Piglets obtain local passive immunity in the gut by drinking their mother's milk, which directly neutralizes invading coronaviruses.
It should be made clear that IgG in colostrum primarily protects against systemic infections, while sIgA in mature milk is key to protecting local intestinal immunity in piglets. Intramuscular administration of inactivated vaccines mainly induces IgG production and has a limited effect on increasing sIgA levels in mature milk. In positive herds, inactivated vaccination can be boosted on the basis of natural infection to further increase the efficiency of sIgA production.
6 types of common porcine coronaviruses form the foundational pathogen pool for disease prevention in the industry today. We must establish a precise pathogen identification framework to avoid misjudgments that could render prevention and control plans ineffective.
The development of the immune system in newborn piglets has an objective time threshold: stable active immune protection can only be established after 3 weeks of age. Interference from maternal antibodies further reduces the effectiveness of vaccination during the newborn stage.
The industry has long been guided by the habitual thinking of “prioritizing treatment for piglets.” In reality, once piglets become ill, the window for intervention is extremely narrow, and the return on investment in treatment is very low.
We need to shift the focus of prevention and control earlier by completing sow immunization in advance and leveraging secretory IgA in colostrum to establish a passive intestinal immune barrier for newborn piglets, reducing the likelihood of illness at the source.
When choosing immunization strategies for porcine coronavirus prevention and control, the core objective must be clear: obtaining sIgA in colostrum. Conventional intramuscular inactivated vaccines have difficulty meeting this need.
Feedback feeding relies on live-virus stimulation of the intestinal mucosa and can rapidly raise sIgA levels, but operational requirements must be strictly controlled. Piglet specimens with typical symptoms appearing within 7 days of age must be selected and processed briefly at low temperatures to avoid inactivating the virus. It must also be implemented across the entire farm at the same time to prevent the spread of wild-type virus. Inactivated vaccines offer greater safety and can raise IgG levels in serum and colostrum, but have a limited effect on sIgA in regular milk. They are suitable as a basic protective measure for negative farms.
In practice, negative farms rely on inactivated vaccines to establish a basic immune barrier, while positive farms combine feedback feeding with post-infection booster immunization to jointly suppress the risk of viral transmission. These are not mutually exclusive options; rather, they should be matched to the virus-carrying status of the pig farm to meet the immunization needs of different settings precisely.
Many people regard feedback feeding as simply “mixing diseased material into feed.” This is a typical misconception. In our review of numerous feedback-feeding failures, we found that eight tenths of the problems were not caused by the virus itself, but by the condition of the pigs. Feedback feeding is a precise live-virus stimulation method, not a reckless operation that spreads pathogens indiscriminately. Every detail directly determines the immune effect.
First, there are strict requirements for selecting diseased material. Feedback feeding must use tissue from piglets showing typical symptoms within 7 days of age. After collection, the tissue must be handled briefly at a low temperature. Exposure to high temperatures or strong sunlight will directly inactivate the virus. Diseased material from pigs with atypical symptoms or pigs older than the specified age does not contain a sufficient effective viral load to stimulate the intestinal mucosa to produce enough secretory IgA.
Next are the prerequisites for controlling underlying diseases. In herds where underlying diseases such as pseudorabies and swine fever are not stable, the immune response is greatly weakened by co-infection. Underlying diseases must be stabilized before feedback feeding is carried out; otherwise, immune responses will be uneven and unable to provide uniform protection.
Finally, sow health is a key factor. PRRS and mycotoxins can directly damage the intestinal mucosal barrier. Even if feedback feeding is carried out in compliance with requirements, sows may still be unable to produce sufficient sIgA, and piglets may continue to develop sporadic cases. The sows’ suboptimal health must first be addressed to provide a good foundation for mucosal immunity.
Porcine coronavirus spreads rapidly, and mistakes in prevention and control can directly affect the entire herd. We will break down, one by one, five non-negotiable prevention and control rules distilled from past frontline cases. Each rule corresponds to lessons learned from real losses on pig farms.
Using material from pigs that have died of disease for feedback feeding at will will artificially spread wild-type viruses and greatly expand the area of viral contamination; relying solely on injections to raise serum antibody levels while neglecting intestinal mucosal immunity will result in insufficient secretory IgA in colostrum, leaving piglets’ intestines still exposed to the threat of viruses; moving pigs between barns to visit other pigs will break biosecurity boundaries, and an outbreak in a single pig barn can spread throughout the entire farm within three days; neglecting basic control of PRRS and mycotoxins will directly suppress the herd’s mucosal immune response, rendering all prevention and control measures ineffective.
Biosecurity is the foremost prerequisite for preventing and controlling all swine diseases. Only by first cutting off the pathways of viral transmission can all immunization interventions truly take effect.
To sum up, we first established that there are 6 common coronaviruses in pigs. Note that newborn piglets can develop solid immunity only after 3 weeks of age. This timing is the core basis for developing prevention and control strategies.
Many farmers directly diagnose piglet diarrhea as PED, overlooking virus typing and missing the optimal time for prevention and control. The data show that piglets cannot develop their own protective immunity in time, and maternal antibodies can also interfere with vaccine efficacy. Therefore, protection must be put in place in advance for the sow population, providing protection for piglets by improving the mothers' immune status.
Once these key data are clarified, follow-up measures can be tailored to pathogen typing and immune mechanisms to develop targeted prevention and control plans, reducing the risk of piglet infection at the source.